Let’s break the stigma of Vitiligo together. Help us discover potential treatments for Vitiligo by enrolling in our HIPAA-compliant clinical trials.
Let’s Overcome
Vitiligo
Vitiligo causes white patches or depigmentation of the skin; it is the most common form of vitiligo. It affects around 0.5% – 2% of the population globally. Vitiligo can occur at any age and affects people of all races and ethnicities. Currently limited treatment options include topical steroids, vitamin D3, calcineurin inhibitors, topical immunomodulators, phototherapy, surgical treatments, and camouflage. MetroBoston is conducting clinical trials in vitiligo to determine the safety and efficacy of new potential treatments that may improve skin pigmentation.
form will be displayed here
![](https://clients.daxdemos.com/mbcp/wp-content/uploads/2023/05/Vitiligo.jpg)
Safety, efficacy, and Tolerability Evaluation
Eligibility Criteria
Enroll in our Vitiligo clinical trial and help us untether the complications of Vitiligo.
Age
10-19 Years & Above
Gender
Male and Female
Current Status
Recruiting
Total Studies
01
Location
Brighton – Boston